baber/WOPTO huggingface dataset:
Patent FI-852854-A0 (FI)
Inventor: BURGESS LESTER E
IPC: B03D1/02
Filed: 1985-07-22
Abstract: An improved method and apparatus for froth flotation separation of the components of a slurry, having particular utility for the beneficiation of coal by the flotation separation of coal particles from impurities associated therewith such as ash and sulfur. In this arrangement, a forward product stream is formed in which a first quantity of chemical reagents is mixed with the particulate matter slurry. The treated particulate matter slurry is then sprayed through a nozzle onto the surface of water in a forward stream flotation tank to create a floating froth phase containing therein a first quantity of the particulate matter. The remainder of the particulate matter slurry separates from the froth phase by sinking in the water, and the froth phase is separated as a first product. The remainder of the particulate matter slurry is then directed to a scavenger product stream in which an additional quantity of chemical reagents is mixed with the remainder of the separated particulate matter slurry. The mixture is then sprayed through a second nozzle onto the surface of water in a second scavenger stream flotation tank to create a floating froth phase containing therein a second quantity of the particulate matter. The remainder of the particulate matter slurry separates from the second froth phase by sinking in the water, and the second froth phase is then separated as a second product. The amounts of the products recovered in the first and second product streams are substantially independently adjustable by controlling the amounts and types of chemical reagents added in each stream.
Patent FI-862303-A0 (FI)
Inventor: JACKMAN ANN LESLEY
IPC: C07D333/00
Filed: 1986-05-30
Abstract: Quinazoline derivatives of the formula 
<CHEM>
 wherein R is
 1) hydrogen
 or 2) a straight or branched chain saturated or unsaturated hydrocarbon group, or 
 3) a straight or branched chain saturated or unsaturated hydrocarbon group which is substituted by at least one heteroatom, the or each heteroatom being halogeno when R is a C1 hydrocarbon group, by a saturated carbocyclic group or by a group containing at least one heteroatom, the or each heteroatom being O, N or S when R contains a cyclic group;
 n is 0, 1 or 2; Z represents-CH=CH- or -O- or -S-; X or,when n is an integer of at least 2, each X independently, represents a halogeno, C1-C4 alkyl, aryl or aralkyl group or a group including at least one heteroatom and Y represents a group of formula: 
<CHEM>
Patent FI-862756-A0 (FI)
Inventor: BARALLE FRANCISCO E
IPC: C07H21/04
Filed: 1986-06-27
Abstract: The polypeptide sequence of the collagen-binding and fibrin-binding parts of fibronectin and the corresponding cDNA sequences have been determined. The collagen-binding polypeptide is useful in methods of purification and the fibrin-binding polypeptide is useful for targetting therapeutic substances on natural fibrin.
Patent FI-864290-A0 (FI)
Inventor: HAGELIN KUNTO
IPC: B62B3/02
Filed: 1986-10-23
Abstract: The hand trolley has a bottom frame equipped with a front pair of swiveling wheels, a rear pair of swiveling wheels and one or two non-swiveling central wheels located at a lower level than the plane defined by the front and rear pairs of wheels. The bottom frame of the trolley is constituted by two lateral bars and two central bars placed respectively on opposite sides of the longitudinal plane of symmetry of the trolley, the rear ends of the central bars being closer to the plane of symmetry than the front ends and the bottom frame being thus M-shaped when viewed from the rear. The central wheels are placed beneath the central bars while the front wheels are placed at the same location as the common front ends of the lateral bars and of the central bars, the rear wheels being placed at the same location as the rear ends of the lateral bars.
Patent FI-874843-A0 (FI)
Inventor: EKBOM RAGNAR
IPC: B22F5/00
Filed: 1987-11-03
Abstract: PCT No. PCT/SE87/00101 Sec. 371 Date Dec. 21, 1987 Sec. 102(e) Date Dec. 21, 1987 PCT Filed Mar. 4, 1987 PCT Pub. No. WO87/05241 PCT Pub. Date Sep. 11, 1987.Method of manufacturing metal products from a powder (19) which is received in a mould cavity formed by a gas-tight casing (10, 11, 12, 13) and is isostatically hot pressed in the casing to form a monolithic body. A body (14) of graphite, hexagonal boron nitride, or another similar ceramic material is provided as a core in the mould cavity, and after the isostatic hot pressing this core is removed from the produced monolithic body by blasting.
Patent FI-875185-A0 (FI)
Inventor: DE AMBROSI LUIGI
IPC: C08B37/04
Filed: 1987-11-24
Abstract: A process for the controlled preparation of low molecular weight glucosaminoglycans by treating conventional high molecular weight glucosaminoglycans in the solid state or in solution form with a rectilinear gamma ray beam at doses within the range of 2.5 to 20 Mrad supplied by successive irradiation stages with cooling intervals between one irradiation stage and the next in the dynamic phase. The mixture obtained is subjected to fractionation, purification, neutralisation and lyophilization. The glucosaminoglycans obtained have a molecular weight of between 1000 and 35,000 daltons and are used for the preparation of pharmaceutical compositions possessing antithrombotic, fibrinolytic, antiatherogenic and heparin cofactor II activation activity.
Patent FI-884267-A0 (FI)
Inventor: COSTE CHRISTIAN
IPC: D21C9/153
Filed: 1988-09-16
Abstract: Process for the ozone treatment of lignocellulosic material, especially of paper pulp, according to which the material is brought to the desired moisture content beforehand in order that the ozonation reaction may take place under optimum conditions, characterised in that the material brought to the desired moisture content is reduced to a sufficient state of division to ensure an interface of maximum value between the ozone-carrier gas and the fibrous solid and in that the said material is then subjected to ozonation by means of a carrier gas in which the ozone concentration is between 4 and 10% on a mass basis in relation to the said carrier gas. <IMAGE>
Patent FI-884280-A0 (FI)
Inventor: SINNREICH JOEL
IPC: A61K9/22
Filed: 1988-09-16
Abstract: The orally administered forms remain in the stomach during the periodic evacuation and ensure continuous release. These solid forms contain the following constituents:
 a) at least one component which expands on contact with body fluid and has a physiologically active substance or a combination of such substances,
 b) at least one membrane which is permeable, is able to expand at the site of use and envelops component a) and, where appropriate,
 c) a covering which envelops component a) and membrane b) and which disintegrates without delay by the action of body fluid at the site of use.
Patent FI-903219-A0 (FI)
Inventor: KONO YOSHITSUGU
IPC: C07D209/20
Filed: 1990-06-26
Abstract: A process for purifying tryptophan is disclosed. In the process of the present invention, tryptophan is recrystallized in water-containing acetic acid. By the process of the present invention, tryptophan with high purity may be obtained with high yield without condensation or neutralization.
Patent FI-912733-A0 (FI)
Inventor: GEORGE PASCAL
IPC: A61P9/10
Filed: 1991-06-06
Abstract: [(1-Arylpyrrolidin-2-yl)methyl]piperazine compounds corresponding to the formula   <IMAGE> (I)  in which Z denotes a group of formula N-R1 in which R1 is either a hydrogen atom or a C1-3 alkyl group or a group of formula Ar-CnH2n in which n denotes 0, 1 or 2 and Ar denotes a phenyl group optionally substituted by one or more halogen atoms and/or C1-3 alkyl or C1-3 alkoxy radicals, or a group of formula COR2 in which R2 denotes the CH3, C6H5, CH2C6H5 or OC2H5 group and their salts of addition to pharmaceutically acceptable acids. The compounds are useful for the treatment of neurological disorders.
Patent FI-913943-A0 (FI)
Inventor: LARSSON LARS-GUNNAR
IPC: A61P25/20
Filed: 1991-08-21
Abstract: Compounds of formula (I), processes for their preparation, pharmaceutical preparations, use of and method of treatment of disorders in CNS by using compounds of formula (I).
Patent FI-914683-A0 (FI)
Inventor: EGGLER JAMES F
IPC: A61K31/35
Filed: 1991-10-04
Abstract: Substituted chromans which by inhibiting 5-lipoxygenase enzyme are useful in the prevention or treatment of asthma, arthritis, psoriasis, ulcers, myocardial infarction, stroke and related disease states in mammals, pharmaceutical compositions thereof, a method of treatment therewith, and to intermediates useful in the synthesis thereof.
Patent FI-923050-A0 (FI)
Inventor: CARTER ADRIAN
IPC: A61P25/18
Filed: 1992-07-01
Abstract: Benzomorphane derivs. of formula (I) are new. In (I), X = O or S; R1 = 1-8C alkyl, 3-6C alkenyl, 3-6C alkynyl or aryl; R2 = H, 1-8C alkyl, 3-6C alkenyl, 3-6C alkynyl, aryl or aralkyl; R3 = H or 1-6C alkyl; R4 and R5 = each 1-8C alkyl; R6 = 1-8C alkyl or aryl; R7 and R8 = each H, 1-8C alkyl, halogen, OH, 1-8C alkoxy, O-Acyl, CN, NO2, NH2, NH(1-8C alkyl), N(1-8C alkyl)2 (n which the alkyl gps. are opt. different), NH-acyl or N-acyl-(1-8C alkyl).
Patent FI-923737-A0 (FI)
Inventor: ADAIR JOHN ROBERT
IPC: C12N15/11
Filed: 1992-08-20
Abstract: Recombinant, in particular humanised, e.g. humanised chimeric and CDR-grafted humanised, antibody molecules having specificity for human TNF alpha , are provided for use in diagnosis and therapy. In particular the antibody molecules have antigen binding sites derived from murine monoclonal antibodies CB0006, CB010, hTNF3 or 101.4. Preferred CDR-grafted humanised anti-hTNF alpha  antibodies comprise variable region domains comprising human acceptor framework and donor antigen binding regions and wherein the frameworks comprise donor residues at specific positions. The antibody molecules may be used for therapeutic treatment of human patients suffering from or at risk of disorders associated with undesirably high levels of TNF, in particular for treatment of immunoregulatory and inflammatory disorders or of septic, endotoxic or cardiovascular shock. <IMAGE>
Patent FI-924388-A0 (FI)
Inventor: FUNK GUIDO
IPC: C08F10/02
Filed: 1992-09-30
Abstract: In a new process for the preparation of a supported catalyst for the polymerisation of  alpha -olefins, first a support gel (1) is prepared by introducing a sodium water glass or potassium water glass solution into a swirling stream of an aqueous mineral acid optionally containing aluminium ions longitudinally and tangentially to the stream, spraying the resultant silicic acid hydrosol in drop form into a gaseous medium, and allowing it to solidify to form a hydrogel, and freeing the resultant hydrogel, without prior ageing, from salts by washing and optionally from some of the water by extraction with alcohols and/or ketones, and then drying the hydrogel. This gives the support gel (1), which is ground and fractionated according to particle size. In a second process step, the support gel (1) is charged with chromium trioxide or with a chromium compound which can be converted into chromium trioxide, after which the resultant chromium-containing support gel (2) is heated at from 400 to 1100 DEG C for from 10 to 1000 minutes in an anhydrous gas stream containing oxygen in a concentration greater than 10% by volume. It is essential for the process according to the invention that the drying of the hydrogel to form the support gel (1) takes place in a high-speed drier within a maximum time of 300 seconds at an inlet temperature of from 200 to 600 DEG C. The supported catalyst prepared in this way gives homopolymers and copolymers of ethylene having excellent low-temperature toughness.
Patent FI-930772-A0 (FI)
Inventor: GOLDSTEIN STEVEN WAYNE
IPC: C07D263/32
Filed: 1993-02-22
Abstract: Certain 1-(benzyl or 5-benzofuranylmethyl)-1-hydroxyurea derivatives are useful as hypoglycemic and hypocholesterolemic agents.
Patent FI-950328-A0 (FI)
Inventor: JOHANSSON JOERGEN
IPC: F21V17/10
Filed: 1995-01-26
Abstract: A work piece (1) for a frame structure (29) for en electrical light fitting, designed to be recessed into a ceiling or wall opening, consists of a planar metal strip having mitre cuts (10,11), which are located at the ends of said strip and are mirror-symmetrically disposed in relation fo each other. In accordance with the invention transversal end surfaces (12,13) are located in connection with said mitre cuts at the ends (2,3) of the strip, the one of said end surfaces (12) being provided with an axially porjecting lock tongue (14) and the other of them (13) in close connection with an oblong hole (16), designed to receive the lock tongue. Also, the metal strip according to the invention is along its length provided with mirror-symmetrically disposed mitre cut pairs (10', 11'), in connection with which transversal end surfaces (12',13') are arranged, which are joined to each other by means of bridge portions, which form lock devices (23). Each lock device consists of a tongue (14') and a fork portion (19), which extends from the tongue and which , when the strip is folded about the symmetry plane, which extends through each mitre cut pair, is folded and is brought to abut on the outer side of one of the inner frame sides (30). The invention also relates to a frame structure, manufactured from such a work piece as well as a method to manufacture such a frame structure. <IMAGE>   <IMAGE>
Patent FI-960264-A0 (FI)
Inventor: BANKS BERNARD JOSEPH
IPC: C07H17/08
Filed: 1996-01-19
Abstract: PCT No. PCT/EP94/02297 Sec. 371 Date Dec. 22, 1995 Sec. 102(e) Date Dec. 22, 1995 PCT Filed Jul. 8, 1994 PCT Pub. No. WO95/03317 PCT Pub. Date Feb. 2, 1995This invention is directed to novel antiparasitic compounds of formula (I), wherein the broken line represents an optional bond, R1 and R4 being absent when this bond is present, R1, R3, R4 are independently H, OH, halo mercapto, oxo, oximino, or an organic radical, R2 and R7 are organic radicals, R6 is H or an organic radical and R12 is OH, halo, C1-C8 alkoxy, C1-C9 alkanoyloxy, or oximino optionally O-substituted by a C1-C8 alkyl, alkenyl, alkynyl, aryl, trialkylsilyl, aralkyl or C1-C9 alkanoyl group.
Patent FI-961745-A0 (FI)
Inventor: BERGERUS CHRISTER
IPC: G01N3/08
Filed: 1996-04-23
Abstract: PCT No. PCT/SE95/01010 Sec. 371 Date May 8, 1996 Sec. 102(e) Date May 8, 1996 PCT Filed Sep. 8, 1995 PCT Pub. No. WO96/07871 PCT Pub. Date Mar. 14, 1996A measuring device is provided for measuring one or more properties, such as thickness and tension profiles of a thin object, especially a fabric. The measuring device includes an upper mobile member adapted to be placed on the top side of the thin object, a lower mobile member adapted to be placed on the bottom side of the thin object, directly below the upper mobile means, magnets for holding together the upper and the lower mobile members with the thin object in between without damaging the thin object, and a measuring device provided on at least one of the mobile members for measuring the properties of the thin object. The mobile members are moveable together or separately across the surface of the thin object.
Patent FI-970979-A0 (FI)
Inventor: HARRISON RICHARD ALEXANDER
IPC: A61K47/48
Filed: 1997-03-07
Abstract: Narrative complement pathway proteins modified such that the protein is capable of forming a stable C3 convertase. Preferably the modified protein is a modified human C3 protein. DNA sequences encoding such proteins are also provided, together with DNA constructs. Conjugates comprising such proteins and a specific binding moiety, for example an antibody, are also described, as are uses of such proteins and/or conjugates in therapy.
Patent FI-991237-A0 (FI)
Inventor: ALIN JARI
IPC: F26B17/10
Filed: 1999-05-31
Abstract: A method and an arrangement for treating wet material which is difficult to treat, such as sewage sludge, by combustion, wherein the material being treated is dried in a steam dryer (3) and the dried matter is combusted in a combustion apparatus (1). For the heat requirement of the steam dryer (3), steam is superheated by the aid of the thermal energy generated by the material combusted in the combustion apparatus (1), and the superheated steam is taken to the steam dryer (3) for drying the material being treated. The amount of heat released from the fuel in the combustion apparatus (1) is transferred into the steam circuit of the steam dryer (3) in its entirety.
Patent IL-79951-A0 (IL)
Title: Substituted 2-phenylhexahydro-1,2,4-triazine-3,5-diones,a process for their preparation,agents containing them,and their use
IPC: C07D253/075
Filed: 1986-09-05
Abstract: Compounds of the formula I    <IMAGE>  (I)  with n=1-3, R=H, Hal, CF3, alkyl, cycloalkyl, alkyloxy, alkylthio, alkylsulfinyl, alkylsulfonyl, benzylsulfinyl, benzylsulfonyl, nitro, cyano, amino, alkylamino, dialkylamino, piperidino, morpholino, pyrrolidinyl, 4-methyl-1-piperazinyl, acylamino or substituted phenoxy, phenylthio, phenylsulfinyl, phenylsulfonyl, benzoyl, benzoylamino or anilino, with R2=H, alkyl, cycloalkyl, optionally substituted benzyl, alkanoyl or benzoyl and R3=H, alkyl, cycloalkyl or optionally substituted benzyl, at least R2 or R3 not being H, are obtained by alkylation or acylation of a compound II    <IMAGE> (II)  in which R1 is as defined above, with compounds R3X (X=leaving group) or R2Y (Y=leaving group), R2 and R3 being defined as indicated. Compounds I are coccidiostatics.
Patent IL-81030-A0 (IL)
Title: Aqueous solutions containing organic anions,for fluid therapy
IPC: A61M1/00
Filed: 1986-12-18
Abstract: Processes and compositions are provided for accomplishing fluid therapy using the anions l-lactate, pyruvate, d-betahydroxybutyrate, acetoacetate, or mixtures of such. The racemic d,l-lactate or acetate anion mixtures heretofore used in fluids are now known not to be desirable because they cause adverse and toxic effects when administered to mammals.
Patent IL-87766-A0 (IL)
Title: Absorbent product and its manufacture
IPC: A61F13/53
Filed: 1988-09-15
Abstract: Disclosed is a laminated structure for use in an absorbent product comprising a hydrophobic liquid-transfer layer adjacent to a fluid permeable top sheet, and an absorbent layer. The hydrophobic layer comprises a thermally consolidated blend of 5% to 50% of thermally bondable hydrophobic fibers and 50% to 95% wood fluff pulp.
Patent IL-92758-A0 (IL)
Title: Composite polyester films useful in particular as support for magnetic recording material and their production
IPC: C08J7/046
Filed: 1989-12-18
Abstract: Composite films comprised of an unloaded semicrystalline polyester film support with a roughness Ra no greater than 0.01  mu m having, on at least one of its faces, a coating based on a modified polymer produced by polymerising one or several acrylic monomers in the presence of a water-dispersable sulphonated copolyester.  The composite films according to the invention are particularly well suited as supports for thin magnetic films.
Patent IL-93913-A0 (IL)
Title: Apparatus for processing signalling messages in an asynchronous time division telecommunications network
IPC: H04L5/22
Filed: 1990-03-27
Abstract: The device comprises a protocol processing circuit (CTP) connected to a network (TTA), a memory (M) having a transmission memory and a reception memory, a transmission control memory (FE) and a reception control memory (FR). The memories are connected to the processing circuit via a data bus (BD) and to a processor for processing the level 2.2 via a bus (BP). The control memories are of the FIFO type, the transmission control memory (FE) being written by the processor and read by the processing circuit, and the reception control memory (FR) being written by the processing circuit and read by the processor. The processing circuit (CTP) transmits and receives cells containing signalling information, and ensures the level 2.1 functions of the protocol: detection of transmission errors cell by cell, detection of losses or additions of cells, fragmentation into cells of a message delivered by the processor and deinterlacing of the cells relating to several messages on reception. 
<IMAGE>
Patent IL-101034-A0 (IL)
Title: 1-biphenylimidazole derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
IPC: A61K31/4178
Filed: 1992-02-21
Abstract: N-Phenylbenzyl imidazole derivs. of formula (I) and their pharmaceutically acceptable salts and esters are new. In (I), R1 = 1-6C alkyl or 3-6C alkenyl; R2 and R3 = H, 1-6C alkyl, 3-6C alkenyl, 3-10C cycloalkyl (opt. polycyclic), aryl(1-6C)alkyl, aryl or aryl fused to 3-10C cycloalkyl; R4 = H, 1-6C alkyl, 1-6C alkanoyl (opt. substd. by one or more halo or 1-6C alkoxy if other than formyl), 3-6C alkenoyl, arylcarbonyl, 1-6C alkoxycarbonyl, tetrahydropyranyl, tetrahydrothiopyranyl, tetrahydrothienyl or tetrahydrofuryl (these 4 opt. substd. by one or more halo or 1-6C alkoxy), SiRaRbRc, 1-6C alkoxymethyl, 1-6C alkoxy(1-6C)alkoxymethyl, halo(1-6C)alkoxymethyl, 1-6C alkyl substd. by at least one aryl, or 1-6C alkanoyl-oxymethoxycarbonyl; Ra, Rb and Rc = 1-6C alkyl or aryl, but not all aryl; R5 = COOH or CONR8R9; R8 and R9 = H, 1-6C alkyl (opt. substd. by at least one (a)) or together are 2-6C alkylene opt. substd. by at least one COOH or alkoxycarbonyl; R6 = H, 1-6C alkyl or alkoxy, or halo; R7 = COOH or tetrazol-5-yl; (a) = aryl, 5-6 membered heterocyclic with 1-4 N, O and/or S, halo, OH, 1-6C alkoxy, COOH, 1-6C alkoxycarbonyl, NH2 or acylamino (acyl = 1-6C alkanoyl or arylcarbonyl); aryl = 6-14C aromatic carbocyclic gp. opt. substd. by at least one of NO2, CN, halo, 6-10C carbocyclic aryl (unsubstd.), 1-6C alkyl or alkoxy, COOH, 1-6C alkoxy-carbonyl, or 1-3C alkylenedioxy or alkylidenedioxy. 23 Cpds. e.g. pivaloyloxymethyl (or (5-methyl-2-oxo -1,3-dioxolen-4-yl)methyl) 4-(1-hydroxy-1-methylethyl) -2-(ethyl, propyl or butyl)-1-(4-(2-tetrazol -5-yl)phenyl)phenyl)methylimidazole -5-carboxylate.
Patent IL-105309-A0 (IL)
Title: Acylaminoindole derivatives
IPC: A61K31/445
Filed: 1993-04-05
Abstract: PCT No. PCT/US93/01807 Sec. 371 Date Sep. 14, 1994 Sec. 102(e) Date Sep. 14, 1994 PCT Filed Mar. 4, 1993 PCT Pub. No. WO93/21180 PCT Pub. Date Oct. 25, 1993.    <IMAGE>  (I)  Compounds of formula (I) where n is 0, 1, or 2; m is 0 or 1; Y and W are each an amino acid residue; R1 is hydrogen, C1-C6 alkyl, C3-C6 alkenyl, C3-C6 alkynyl, aryl, C1-C3 alkylaryl, or C1-C3 alkylheteroaryl, and -(CH2)pR3; R2 is CF3, C1-C6 alkyl, aryl, C1-C3 alkylaryl, and -OR5; R3 is cyano, trifluoromethyl, or -OR4; R4 is hydrogen, C1-C6 alkyl, C1-C3 alkylaryl, or aryl; R5 is C1-C6 alkyl, C1-C3 alkylaryl, or aryl; R6 is hydrogen, -OR7, or -NHCOR7; R7 is hydrogen, C1 to C6 alkyl, aryl or C1 to C3 alkyl-aryl; p is 1, 2, or 3; and the above aryl groups and the aryl moieties of the above alkyl-aryl groups are independently selected from phenyl and substituted phenyl, wherein said substituted phenyl may be substituted with one to three groups selected from C1 to C4 alkyl, halogen, hydroxy, cyano, carboxamide, nitro, and C1 to C4 alkoxy and the pharmaceutically acceptable salts thereof. These compounds are useful in treating migraine and other disorders. These compound are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, and chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.
Patent IL-117115-A0 (IL)
Title: Process for preparing recombinant adenovirus genomes
IPC: C12N15/34
Filed: 1996-02-12
Abstract: A novel method for preparing recombinant adenoviruses and the use of such adenoviruses in gene therapy are disclosed. Plasmids used in the construction of said adenoviruses are also disclosed.